Beta Bionics
BBNX
Beta Bionics (BBNX) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| William Blair | Initiated Coverage | Market Perform | — | Aug 21, 2026 |
| UBS | Initiated Coverage | Buy | $22.00 | Jul 28, 2026 |
| Goldman Sachs | Maintained | Buy | $19.00 from $17.00 | Jul 15, 2026 |
| Truist Securities | Maintained | Buy | $22.00 from $18.00 | Jul 13, 2026 |
| Goldman Sachs | Maintained | Buy | $17.00 from $19.00 | May 27, 2026 |
| B of A Securities | Maintained | Neutral | $11.00 from $23.00 | May 18, 2026 |
| Stifel | Maintained | Buy | $20.00 from $22.00 | Apr 22, 2026 |
| Leerink Partners | Maintained | Outperform | $24.00 from $25.00 | Apr 22, 2026 |
| Truist Securities | Maintained | Buy | $18.00 from $25.00 | Apr 15, 2026 |
| Goldman Sachs | Maintained | Buy | $20.00 from $23.00 | Apr 9, 2026 |
| Stifel | Maintained | Buy | $22.00 from $25.00 | Feb 18, 2026 |
| Baird | Maintained | Neutral | $14.00 from $28.00 | Feb 18, 2026 |
| Stifel | Maintained | Buy | $25.00 from $31.00 | Feb 4, 2026 |
| Truist Securities | Maintained | Buy | $25.00 from $37.00 | Feb 2, 2026 |
| TD Cowen | Initiated Coverage | Hold | $17.00 | Jan 27, 2026 |
| Lake Street | Maintained | Buy | $40.00 from $35.00 | Jan 9, 2026 |
| B of A Securities | Maintained | Buy | $33.00 from $30.00 | Jan 5, 2026 |
| Truist Securities | Maintained | Buy | $37.00 from $32.00 | Dec 18, 2025 |
| Truist Securities | Maintained | Buy | $32.00 from $28.00 | Oct 29, 2025 |
| Stifel | Maintained | Buy | $31.00 from $26.00 | Oct 29, 2025 |
Frequently asked questions
What is the latest analyst rating on BBNX?
On Aug 21, 2026, William Blair initiated coverage of Beta Bionics at Market Perform.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.